From: Systematic review of outcome measures in pediatric eosinophilic esophagitis treatment trials
 | Konikoff [18] | Schaefer [19] | Dohil [20] | Assa’ad [21] | Spergel [22] | Gupta [23] |
---|---|---|---|---|---|---|
Random sequence generation | + | + | + | ? | + | ? |
Allocation concealment | + | + | + | + | + | + |
Blinding of participants/personnel | + | – | + | + | + | + |
Blinding of outcome assessment | + | + | + | + | + | ? |
Incomplete outcome data | – | + | – | + | + | + |
Selective outcome reporting | ? | ? | + | – | ? | + |
Pharmaceutical sponsorship | + | + | + | – | – | – |